Journal of Medicine, Surgery, and Public Health最新文献

{"title":"Recurrent bilateral lumbar hernia, a case report and literature review","authors":"Osman M. Osman ,&nbsp;Suaad Abdalla Abdu Seneen ,&nbsp;Musab Hamed Ahmed Hamed ,&nbsp;Abubker Elamin Mohamed Abdalla ,&nbsp;Nazzar Atta Doka Aboali ,&nbsp;Doaa Siralkhatim Mohamed Ahmed","doi":"10.1016/j.glmedi.2025.100208","DOIUrl":"10.1016/j.glmedi.2025.100208","url":null,"abstract":"<div><div>Lumbar hernia is a rare condition characterized by protrusion of retroperitoneal contents through a defect in the posterolateral abdominal wall, with fewer than 400 cases reported. Bilateral lumbar hernia is exceedingly rare, and recurrence following surgical repair is even more uncommon. We report a case of a 44-year-old male laborer with recurrent bilateral lumbar hernia who initially presented with bilateral reducible lumbar swellings which were successfully diagnosed as bilateral lumbar hernia and underwent surgical repair using mesh reinforcement. The hernias recurred four months postoperatively, and the patient presented again 2.5 years later. This time, he also experienced lumbosacral back pain with radiation to the right foot. Clinical examination and imaging, including ultrasound and CT scan, confirmed bilateral lumbar hernia recurrence. The patient declined further surgical intervention, opting for conservative management. MRI of the spine also revealed L4/L5 and L5/S1 disc herniations, and a Tarlov cyst. This case highlights the diagnostic and management challenges posed by recurrent bilateral lumbar hernia, particularly in resource-constrained settings. It also highlights the potential coexistence of unrelated spinal pathology, which may complicate symptom interpretation. We review the existing literature and discuss potential risk factors for recurrence, including suboptimal mesh fixation, and the importance of individualized surgical planning. Awareness of this rare condition is crucial for prompt diagnosis and appropriate management.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"7 ","pages":"Article 100208"},"PeriodicalIF":0.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Botropase optimized conjunctival tissue grafting (BOT-Graft): Bridging efficacy, safety, and affordability in primary Pterygium surgery","authors":"Nilesh Kumar","doi":"10.1016/j.glmedi.2025.100205","DOIUrl":"10.1016/j.glmedi.2025.100205","url":null,"abstract":"<div><div>Pterygium excision with conjunctival autografting is the preferred surgical approach for preventing recurrence. However, the ideal method for graft fixation remains debatable. This study describes a novel technique using hemocoagulase (Botropase) for conjunctival autograft fixation in pterygium surgery. Botropase, derived from snake venom, facilitates fibrin matrix formation at the graft-host interface without the drawbacks of traditional methods. Our initial series demonstrated a mean surgical time of 18.3 min, significantly shorter than sutured techniques (32.42 min) and comparable to fibrin glue (20.17 min). The procedure showed excellent graft stability with minimal complications and no recurrences during the follow-up period. At approximately 3 USD per vial, Botropase offers a 95 % cost reduction compared to fibrin glue, making it particularly valuable for high-volume centers and developing economies. This technique represents a promising advancement in pterygium surgery by combining the precision of fibrin glue with the affordability of autologous blood while mitigating their respective limitations.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"7 ","pages":"Article 100205"},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144490128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dementia in Sub-Saharan Africa: Risk factors, public perception, and management approaches","authors":"Zemichael Getu Alemayehu ,&nbsp;Biruk Demisse Ayalew ,&nbsp;Brook Lelisa Sime ,&nbsp;Tsimona Dinku Bonger ,&nbsp;Yonatan Abbawa Zewdie ,&nbsp;Abenezer Shiferaw Keraga ,&nbsp;Henok Wolde Nida ,&nbsp;Temesgen Mamo Sharew ,&nbsp;Beamlak Getachew Woldeselassie ,&nbsp;Mateyas Yohannes Melaku ,&nbsp;Biniyam Alemayehu Ayele","doi":"10.1016/j.glmedi.2025.100204","DOIUrl":"10.1016/j.glmedi.2025.100204","url":null,"abstract":"<div><div>Dementia is becoming a major public health problem in Sub-Saharan Africa (SSA), with prevalence increasing due to demographic transitions, increasing life expectancy, and increasing prevalence of non-communicable diseases. This commentary synthesizes the latest data on the epidemiology, risk factors, public perception, and management approaches for dementia in SSA, noting that although worldwide rates of dementia are increasing, SSA will experience the highest growth, which, with the current rate of increase, is projected to triple by 2050. SSA prevalence rates vary widely from 2.3 % to as high as 20 %, predominantly because of methodological discrepancies, lack of identification, and limited access to medical care. Incidence figures are also weak and mostly restricted to a few countries, thus potentially underestimating the true regional burden. The identified risk factors include age, gender, low educational attainment, untreated hypertension, diabetes, infectious diseases, including causes of HIV and cerebral malaria, and specific genetic predispositions, with low educational status being the most powerful modifiable factor. Stigma and misconceptions often delay diagnosis and contribute to under-reporting, compounding the burden on affected families. The sub-optimal healthcare system, lack of culturally appropriate diagnostics, and national fragmentation of epidemiological data make the situation of SSA more complex. The commentary emphasizes the importance of raising awareness, data collection method refinement, and culturally informed approaches to guide policy-making, promote research, and enhance the prevention and management of dementia in SSA, to develop locally-suited interventions to address the growing dementia epidemic.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"7 ","pages":"Article 100204"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144271077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Engaging community members in health-related research and interventions","authors":"Jagdish Khubchandani,&nbsp;Elizabeth England-Kennedy,&nbsp;Michael Wiblishauser,&nbsp;Karen Kopera-Frye,&nbsp;Fern J. Webb","doi":"10.1016/j.glmedi.2025.100203","DOIUrl":"10.1016/j.glmedi.2025.100203","url":null,"abstract":"<div><div>The landscape of public health intervention planning and conducting clinical research has changed a lot in the 21st century with profound alterations occurring since the COVID-19 pandemic. However, the one fundamental, often challenging, but undermined aspect is the involvement of the general public in medical research or community health interventions. This editorial underscores the paramount significance of involving community members in clinical research or public health interventions to enhance their relevance, effectiveness, and sustainability. We introduce a framework based on six essential domains, referred to as the \"Six Cs\" (i.e. Constituents &amp; Connections; Communication &amp; Cultivation of Trust; Cultural Competency &amp; Conduct Norms; Context, Capacity &amp; Constraints; Creation of Procedures &amp; Protocols; and Commitment to Common Goals). For medical research and community health interventions, this framework emphasizes the need for collaborative, transparent, and culturally sensitive methodologies that can enhance the general public’s engagement. By nurturing authentic partnerships and utilizing community expertise, this framework for community-engaged health research seeks to improve public participation, foster trust, ensure ethical practices, and ultimately realize significant health outcomes for the public and scientific community.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100203"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144261613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of female sexual dysfunction in Africa: A systematic review and meta-analysis","authors":"Andy-Muller Luzolo Nzinga ,&nbsp;Véronique Feipel ,&nbsp;Jeanne Bertuit","doi":"10.1016/j.glmedi.2025.100202","DOIUrl":"10.1016/j.glmedi.2025.100202","url":null,"abstract":"<div><div>Female Sexual Dysfunction (FSD) is a multifactorial health issue influenced by physiological, psychological, and sociocultural factors. Despite a global prevalence of ,10–63 %, FSD is underrecognized in African contexts due to cultural taboos and limited healthcare access. This review and meta-analysis aim to assess FSD prevalence and risk factors across Africa, guiding culturally sensitive interventions, policies, and future research to improve women's sexual health. Following PRISMA guidelines, a systematic search was conducted in databases including PubMed, Embase, CINAHL, and African Journals Online (AJOL) for studies published between 2000 and 2023. Eligible studies reported FSD prevalence in African women aged 18 years and older. A meta-analysis of pooled prevalence was conducted using a random-effects model, with heterogeneity assessed using I² and Cochran’s Q tests. Thirteen studies involving 11,585 women from five African countries met the inclusion criteria. The pooled prevalence of FSD was 52.1 % (95 % CI: 45.7–58.4 %), with significant heterogeneity (I² = 97.1 %). Regional prevalence rates ranged from 39 % in East Africa to 61 % in West Africa (p = 0.051). The pooled prevalence was 76.2 % for desire disorder; 59.7 %for arousal disorder; 73.7 % for lubrication; 73.1 % for orgasm disorder; 60.6 % for sexual dissatisfaction and 51.6 % for pain/dyspareunia. The diagnostic tool used influenced prevalence estimates, with the Female Sexual Function Index (FSFI) reporting lower rates (44 %) compared to other tools (70 %) (p &lt; 0.001). FSD affects over half of African women, underscoring the need for standardized diagnostic criteria, increased awareness, and culturally appropriate interventions to address this pervasive issue and improve women’s quality of life.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"7 ","pages":"Article 100202"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144230038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rectus abdominis endometriosis presenting as a menstruation-linked abdominal mass","authors":"Derar I.I. Ismerat ,&nbsp;Barah K.S. Alsalameh ,&nbsp;Majd Oweidat","doi":"10.1016/j.glmedi.2025.100201","DOIUrl":"10.1016/j.glmedi.2025.100201","url":null,"abstract":"<div><div>Rectus abdominis endometriosis (RAE) is a rare form of extra-pelvic endometriosis, often associated with prior surgical or gynecological procedures. We report a case of a woman in her early 30 s who presented with an eight-month history of a painful, cyclical mass in the left lower abdomen. Her history included a cesarean section, medical abortion, and failed IVF. Imaging identified a 2.3 × 1.5 cm hypoechoic nodule within the rectus abdominis muscle. Surgical excision confirmed endometriotic tissue, and the patient had an uneventful recovery. Histopathology revealed ectopic endometrial glands and stroma within the rectus muscle, consistent with RAE. This case highlights the potential for RAE to occur years after gynecological interventions and in atypical locations, suggesting alternative pathogenic mechanisms such as vascular spread or immune dysregulation. In this patient, delayed presentation and lesion location away from the cesarean scar raise the possibility of multifactorial pathogenesis involving both iatrogenic and non-iatrogenic factors, including hormonal stimulation from IVF. Complete surgical excision led to the resolution of symptoms. Clinicians should consider RAE in patients presenting with cyclical abdominal wall masses, even in the absence of recent surgery.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100201"},"PeriodicalIF":0.0,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Availability and completeness of real-world data in United States community oncology/hematology practices regarding chimeric antigen receptor (CAR T)-cell therapy for relapsed/refractory diffuse large B-cell lymphoma","authors":"David L. Porter ,&nbsp;Andrew J. Klink ,&nbsp;Alexandrina Balanean ,&nbsp;Tammy Schuler ,&nbsp;Bindu Kalesan ,&nbsp;Richard Scott Swain ,&nbsp;Lindsay McAllister ,&nbsp;Djibril Liassou ,&nbsp;Sarah Lucht ,&nbsp;Ajeet Gajra ,&nbsp;Bruce Feinberg","doi":"10.1016/j.glmedi.2025.100200","DOIUrl":"10.1016/j.glmedi.2025.100200","url":null,"abstract":"<div><div>This retrospective, observational study evaluated real-world data (RWD) completeness for 65 adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor (CAR) T-cell therapy across 11 community practices in 2019. Eligible patients had ≥ 6 months of follow-up, excluding those who died earlier, had CNS metastases, or participated in clinical trials. Physicians abstracted electronic medical records (EMRs) in 2021 using standardized case report forms (eCRFs), capturing demographics, prior therapies, referral/infusion timelines, toxicities, hospitalizations, and survival. Data underwent quality validation. Baseline demographics were fully documented: 70.8 % of patients had good performance status (Eastern Cooperative Oncology Group [ECOG] 0–1), 73.8 % had elevated lactate dehydrogenase (LDH), and 83.9 % were deemed high-risk. Hospitalization and emergency visit records were 100 % complete, whereas toxicity documentation ranged from 86.2 % to 98.5 %. Patients received a median 3 prior therapy lines; key barriers to CAR T-cell therapy referral included patient choice (45.5 %), center location (36.4 %), and logistics (27.3 %). Rapid disease progression precluded treatment in 81.8 % of nonrecipients. Only 43.1 % had leukapheresis dates recorded, with a 4.5-month median from relapse to infusion. Posttreatment, 75.0 % developed cytokine release syndrome (CRS) and 67.7 % had fever. At median 15.5-month follow-up, 44.6 % relapsed and 47.7 % died. Survival (median progression-free survival, 18.6 months; overall survival, 22.8 months) aligned with trials but revealed disparities in real-world delivery, such as manufacturing delays and incomplete documentation. This study underscores feasibility of robust RWD collection in community settings while highlighting critical gaps—particularly in leukapheresis tracking and postinfusion toxicity reporting—that must be addressed to optimize CAR T-cell therapy management.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100200"},"PeriodicalIF":0.0,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144071581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hepatitis C virus-related liver cancer among Medicaid recipients with schizophrenia, 2002–2012","authors":"Marilyn D. Thomas ,&nbsp;Mandana Khalili ,&nbsp;Eric Vittinghoff ,&nbsp;Francine Cournos ,&nbsp;Mark Olfson ,&nbsp;Priya Dahiya ,&nbsp;Stephen Crystal ,&nbsp;Richard Hermida ,&nbsp;Christina Mangurian","doi":"10.1016/j.glmedi.2025.100199","DOIUrl":"10.1016/j.glmedi.2025.100199","url":null,"abstract":"<div><div>Nearly half of primary liver cancers are attributed to hepatitis C virus (HCV) infection. People living with schizophrenia have higher HCV prevalence and liver cancer mortality rates than the general population. Among Medicaid beneficiaries with HCV, we compared incident liver cancer diagnosis in recipients living with and without schizophrenia. Using Medicaid claims data, pooled logistic regression and time survival models we estimated adjusted incidence rates of liver cancer diagnosis and risk factors for those living with schizophrenia. During 2002–2012 (N = 104,469), incident liver cancer diagnosis ranged from 845 to 1602 per 100,000 person-years. Recipients living with versus without schizophrenia had lower diagnosis rates over the study period and lower cumulative incidence within common risk factors of liver disease progression (e.g., diabetes). However, rates were higher for those with comorbid human immunodeficiency virus (HIV) infection. Among recipients with schizophrenia, higher odds of liver cancer diagnosis was associated with having comorbid alcohol use disorder (OR=1.23; 95 % confidence interval [CI] =1.70–2.05), diabetes (OR=1.49; CI=1.36–1.64), hypertension (OR=1.49; CI=1.36–1.65), chronic hepatitis B (OR=2.57; CI=2.26–2.91), or ≥ 1 annual primary care visit (OR=1.65; CI=1.46–1.86). Black (versus White) recipients had lower odds of diagnosis (OR=0.77; CI=0.70–0.86). Given higher HCV prevalence and liver cancer mortality in this population, lower diagnosis rates may reflect insufficient liver cancer detection, potentially driving HCV-related excess mortality rates for individuals living with schizophrenia. Addressing metabolic abnormalities and alcohol use is critical to risk reduction in HCV-infected persons living with schizophrenia, especially those living with HCV-HIV coinfection or racially minoritized.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100199"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143935059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Using thematic analysis in qualitative research","authors":"Sirwan Khalid Ahmed ,&nbsp;Ribwar Arsalan Mohammed,&nbsp;Abdulqadir J. Nashwan,&nbsp;Radhwan Hussein Ibrahim,&nbsp;Araz Qadir Abdalla,&nbsp;Barzan Mohammed M. Ameen,&nbsp;Renas Mohammed Khdhir","doi":"10.1016/j.glmedi.2025.100198","DOIUrl":"10.1016/j.glmedi.2025.100198","url":null,"abstract":"<div><div>Thematic analysis (TA) is one of the most widely utilized methods for analyzing qualitative data, offering a structured yet flexible framework for identifying, analyzing, and interpreting patterns of meaning within datasets. This paper provides a comprehensive overview of Braun and Clarke's six-phase thematic analysis framework, which includes (1) familiarization with data, (2) generating initial codes, (3) searching for themes, (4) reviewing themes, (5) defining and naming themes, and (6) writing the report. Additionally, it presents a 16-item checklist to ensure adherence to the established steps of thematic analysis, enhancing the rigor and reliability of the study. Each phase is explored in-depth, highlighting its purpose, key activities, reflexive considerations, challenges, and significance. Emphasis is placed on the iterative and reflexive nature of TA, where researchers actively engage with data and acknowledge their theoretical positioning and biases throughout the process. Challenges such as data overwhelm, coding inconsistencies, and balancing thematic depth and breadth are addressed, alongside practical strategies for overcoming these obstacles. The importance of transparency, reflexivity, and methodological rigor is underscored as central to producing trustworthy and insightful qualitative research. This article serves as both an academic reference and a practical guide for researchers aiming to apply thematic analysis effectively, ensuring that their findings are presented in a coherent, compelling, and analytically sound manner.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100198"},"PeriodicalIF":0.0,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143844184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bridging the gap: Advancing occupational therapy in cancer recovery for better outcomes","authors":"Amanda dos Santos Pereira ,&nbsp;Alexander Miller ,&nbsp;Amos Olalekan Akinyemi","doi":"10.1016/j.glmedi.2025.100196","DOIUrl":"10.1016/j.glmedi.2025.100196","url":null,"abstract":"<div><div>Cancer is a complex illness that affects millions of individuals worldwide, posing multifaceted challenges to their physical, mental, and social well-being, often hindering engagement in meaningful activities. In recent years, occupational therapy has emerged as a vital component in the comprehensive care of cancer patients, facilitating their recovery and enhancing their quality of life. This commentary explores the intersection of cancer care and occupational therapy, elucidating the role of occupational therapists in addressing the diverse needs of cancer patients across the continuum of care. Drawing on literature published between 2000 and 2025, this commentary synthesizes evidence from peer-reviewed articles, clinical guidelines, and practice-based insights. It emphasizes the importance of advancing occupational therapy interventions in promoting functional independence, managing symptoms, and fostering psychosocial well-being in individuals affected by cancer. Furthermore, it discusses various approaches and techniques employed by occupational therapists in oncology settings, emphasizing the significance of interdisciplinary collaboration to optimizing patient outcomes. By integrating evidence-based insights, this commentary demonstrates the pivotal role of occupational therapy in bridging the gap between cancer treatment and rehabilitation, ultimately contributing to improved recovery and enhanced quality of life for cancer survivors.</div></div>","PeriodicalId":100804,"journal":{"name":"Journal of Medicine, Surgery, and Public Health","volume":"6 ","pages":"Article 100196"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143834949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}